Representative before the EPO

Employment test 501 - 1000 employees
Company dna marks and clerk llp
operating since 1887
1376.1
Headquarter in London and 20 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Representative before the EPO

Employment test 201 - 500 employees
Company dna hgf ltd
operating since 1995
1325.42
Headquarter in Leeds and 20 offices
active in Legal Services and IP Consulting

Representative before the EPO

Company dna bioscience ip limited
no operation time available
1 office
active in Legal Services

We have observed 16 EP applications Paul Clifford Banford has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12818061

ANTIOXIDANT, NEUROPROTECTIVE AND ANTINEOPLASTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT ON AN AMPHIPHILIC SPACER OR AN AMPHIPHILIC POLYMER

IPC classification:
A61K 9/14, A01N 43/26, C07D 405/00, C07D 339/02
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12847179

TRANSCRIPTION FACTOR-BASED GENERATION OF PACEMAKER CELLS AND METHODS OF USING SAME

IPC classification:
A61K 48/00
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP12854115

TARGETING MICRORNAS MIR-409-5P, MIR-379 AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER

IPC classification:
A61K 31/7088, C12Q 1/68, A61P 35/00
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
APPLICATION WITHDRAWN
EP12813077

MICROSENSOR

IPC classification:
C12Q 1/04
Applicant:
University of Manchester
Agent:
Appleyard Lees Ltd
Agent:
Paul Clifford Banford, Bioscience IP Limited
Agent:
Paul Clifford Banford, HGF Limited
Status:
The patent has been granted
EP12762965

METHODS OF DIAGNOSING ULCERATIVE COLITIS AND CROHN'S DISEASE

IPC classification:
G01N 33/68, G01N 33/564, G01N 33/48, C12Q 1/68
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
The patent has been granted
EP13769023

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/7068, A61K 31/5415, G01N 33/15, A61P 35/02
Applicant:
McMaster University
Agent:
Paul Clifford Banford, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13757087

SULFORAPHANE-DERIVED COMPOUNDS, PRODUCTION METHOD THEREOF AND THE MEDICAL, FOOD AND COSMETIC USE OF SAME

IPC classification:
A61K 31/26, C07C 331/20
Applicant:
Universidad de Sevilla - Oficina de Transferencia de Resultados de Investigación (OTRI)
Applicant:
Consejo Superior De Investigaciones Científicas (CSIC)
Agent:
Paul Clifford Banford, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13719356

USE OF TOMATO EXTRACT AS ANTIHYPERTENSIVE AGENT AND PROCESS FOR MAKING WATER SOLUBLE SUGAR FREE TOMATO EXTRACT

IPC classification:
A61K 36/81, A23L 1/30, A61P 9/12
Applicant:
University of Oslo (Universitetet i Oslo)
Agent:
Paul Clifford Banford, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13815828

COMPOSITIONS

IPC classification:
A61K 36/81, A23L 1/00
Agent:
Paul Clifford Banford, Bioscience IP Limited
Agent:
Paul Clifford Banford, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14773989

TREATING FIBROSIS AND INFLAMMATION BY INHIBITING TL1A

IPC classification:
C12Q 1/68, A61K 38/16, A61K 38/12
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
EXAMINATION REQUESTED
EP14826746

SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY

IPC classification:
C12N 5/0783
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14842590

SYSTEMS, DEVICES AND METHODS FOR ANTI-TL1A THERAPY

IPC classification:
A61P 37/06
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14851688

DIAGNOSIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE

IPC classification:
A01N 37/18, G01N 33/554, G01N 33/00, A61K 39/40
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
GRANT OF PATENT INTENDED
EP14795854

TREATMENT OF CANCER AND BENIGN PROLIFERATIVE DISORDERS

IPC classification:
A61P 31/12, A61K 9/48, A61K 9/00, A61P 35/00, A61K 31/505, A61K 31/427
Applicant:
University of Manchester
Agent:
Paul Clifford Banford, HGF Limited
Status:
EXAMINATION REQUESTED
EP11838813

TREATMENT OF PITUITARY CORTICOTROPH TUMORS USING R-ROSCOVITINE

IPC classification:
A61P 35/00, G01N 33/50, A61K 49/00, A61K 38/00, A61K 31/52
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15785256

METHODS OF PREDICTING MEDICALLY REFRACTIVE ULCERATIVE COLITIS (MRUC) REQUIRING COLECTOMY

IPC classification:
C12Q 1/68
Applicant:
Cedars-Sinai Medical Center
Agent:
Paul Clifford Banford, HGF Limited
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature